Key facts
- Rocket Lab's stock has seen a significant rebound, with some analysts deeming a recent selloff misguided.
- Analysts have maintained bullish sentiment, with several raising price targets for the company's stock.
- Rocket Lab reported strong first-quarter revenue growth of 63.50% and a record backlog of $2.2 billion.
- Despite a high market cap and price-to-sales ratio, the stock has shown resilience and potential for further gains.
Rocket Lab's stock has rebounded, with analysts suggesting that a recent selloff, potentially linked to the anticipation of SpaceX's initial public offering (IPO), was misguided. The company's stock has seen significant gains over the past year, soaring 402% and hovering near its all-time high.
Analysts remain largely bullish on Rocket Lab ahead of the anticipated SpaceX IPO, which is expected to be the largest ever with a valuation exceeding $1.5 trillion. This event has prompted investors to rotate into related companies, including Rocket Lab. New Street Research has raised its target price to $150, while Deutsche Bank increased its target from $73 to $120, and Needham set its target at $121. The consensus target for Rocket Lab stock stands at $93, which, while lower than its current trading price, represents a substantial increase from its value a year ago.
Analysts cite Rocket Lab's accelerating revenue growth as a key factor. The company recently reported a 63.50% increase in first-quarter revenue to $200.3 million, alongside a record backlog of $2.2 billion, up over 20% year-over-year. This backlog includes 31 new Electron and HASTE contracts and five new Neutron orders. Projections indicate continued growth, with revenue expected to jump by 58% in the next quarter to $229 million and by 50% annually to $907 million, potentially exceeding $1.2 billion in the following fiscal year.
However, Rocket Lab's substantial market capitalization of $73 billion results in a forward price-to-sales ratio of 81, raising concerns about its valuation. Additionally, there is a risk of a stock price reversal post-SpaceX IPO, a phenomenon known as 'buying the rumor and selling the news.' Technical analysis also suggests potential mean reversion, with the stock possibly dropping to a support level around $100 before a potential bounce.
Despite these risks, analyst sentiment remains strong, with consensus price targets steadily rising. Shares have held significant support and stabilized, with multiple catalysts on the horizon, positioning Rocket Lab for a potential upward trajectory.